| __timestamp | Corcept Therapeutics Incorporated | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 25669000 | 2614539000 |
| Thursday, January 1, 2015 | 48925000 | 3711019000 |
| Friday, January 1, 2016 | 79263000 | 4560733000 |
| Sunday, January 1, 2017 | 155647000 | 5475166000 |
| Monday, January 1, 2018 | 246032000 | 6276700000 |
| Tuesday, January 1, 2019 | 300982000 | 7081200000 |
| Wednesday, January 1, 2020 | 348292000 | 7377200000 |
| Friday, January 1, 2021 | 360697000 | 13634200000 |
| Saturday, January 1, 2022 | 396473000 | 10612500000 |
| Sunday, January 1, 2023 | 475894000 | 11301400000 |
| Monday, January 1, 2024 | 12231500000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated have demonstrated remarkable growth in gross profit, albeit at different scales. From 2014 to 2023, Regeneron's gross profit surged by approximately 332%, reaching a peak of $11.3 billion in 2023. This growth underscores Regeneron's robust market position and innovative product pipeline.
Conversely, Corcept Therapeutics, while smaller in scale, exhibited an impressive 1,755% increase in gross profit over the same period, culminating in $475 million in 2023. This exponential growth highlights Corcept's strategic focus and successful niche market penetration. The data reveals a fascinating narrative of two companies thriving in the biotech sector, each carving out its path to financial success.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Corcept Therapeutics Incorporated
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated's Expenses
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Gross Profit Comparison: Viatris Inc. and Corcept Therapeutics Incorporated Trends
Bio-Techne Corporation vs Corcept Therapeutics Incorporated: A Gross Profit Performance Breakdown
Ascendis Pharma A/S and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs Ligand Pharmaceuticals Incorporated